Published: 03 Dec 20 view(s)
Guardant Health AMEA wins Team of the Year and Executive of the Year at the SBR Management Excellence Awards 2020
Guardant Health Asia, Middle East and Africa (AMEA) was recently awarded two prestigious honours for Team of the Year and Executive of the Year in the Healthcare category at the
Singapore Business Review (SBR) Management Excellence Awards 2020.
The precision oncology company is fully focused on guiding treatment decisions for advanced cancer patients in AMEA. Guardant Health AMEA is creating a paradigm shift in advanced cancer diagnostics beyond invasive tissue biopsies, which are considered as the standard of care. The company’s flagship product, the Guardant360® test, is a breakthrough liquid biopsy which provides quick and accurate comprehensive genomic profiling information from a simple blood draw in seven days upon sample receipt in the laboratory.